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Abstract
Objective—To assess the sensitivities and false detection rates of two CADe systems when
applied to digital or screen-film mammograms in detecting the known breast cancer cases from the
DMIST breast cancer screening population.
Materials and Methods—Available screen-film and digital mammograms of 161 breast cancer
cases from DMIST were analyzed by two CADe systems, iCAD SecondLook (iCAD) and R2
ImageChecker (R2). Three experienced breast imaging radiologists reviewed the CADe marks
generated for each available cancer case, recording the number and locations of CADe marks and
whether each CADe mark location corresponded with the known location of the cancer.
Results—For the 161 cancer cases included in this study, the sensitivities of the DMIST reader
without CAD were 0.43 (69/161, 95% CI 0.35 to 0.51) for digital and 0.41 (66/161, 95% CI 0.33
to 0.49) for film-screen mammography. The sensitivities of iCAD were 0.74 (119/161, 95% CI
0.66 to 0.81) for digital and 0.69 (111/161, 95% CI 0.61 to 0.76) for screen-film mammogram,
both significantly higher than the DMIST study sensitivities (p< 0.0001 for both). The average
number of false CADe marks per case of iCAD was 2.57 (SD 1.92) for digital and 3.06(SD 1.72)
for screen-film mammography. The sensitivity of R2 was 0.74 (119/161, 95% CI 0.66 to 0.81) for
digital, and 0.60 (97/161, 95% CI 0.52 to 0.68) for screen-film mammography, both significantly
higher than the DMIST study sensitivities (p< 0.0001 for both). The average number of false
CADe marks per case of R2 was 2.07 (SD 1.57) for digital and 1.52(SD 1.45) for screen-film
mammogram.
Conclusions—Our results suggest the use of CADe in interpretation of digital and screen-film
mammograms could lead to improvements in cancer detection.
INTRODUCTION
In the Digital Mammographic Imaging Screening Trial (DMIST), the reported sensitivities
for both digital and screen-film mammography were 0.41 based on 455 days of follow-up.1
While low, similar sensitivities for digital and screen-film mammography have been
previously reported, ranging from 0.40 to 0.77 for digital mammography and from 0.31 to
0.71 for screen-film mammography in recently published results from six other controlled
laboratory studies,1-12,13 while the National Breast Cancer Surveillance Consortium
(NBCSC) reported an average screening sensitivity of 81.2% in their analysis of screening
mammography records for over 3.8 million women between 1996 and 200714 based on 365
days of follow-up.3 There is wide variation in reported radiologist sensitivities in these
studies that is likely dependent not only on the skills of the participating radiologists, but
also on the image case sets, the number of rounds of screening, and definitions of
sensitivity15-18. Even so, there is a need for development of tools that improve the detection
of breast cancer; thus the impetus for computer-aided detection software development. We
use the abbreviation CADe to refer to computer-aided detection software, as opposed to the
more ubiquitous CAD, which has been used to reference both computer-aided detection
algorithms and computer-aided diagnostic algorithms. While the former is designed to
prompt the radiologist to regions of a mammogram that may have been overlooked, the
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latter, now frequently referred to as CADx in the literature, is designed to aid radiologists in
distinguishing cancerous lesions from non-cancerous lesions.
It has been noted previously that the cases used to train and ultimately test a CADe system
are the primary drivers on how well that technology will perform in cancer detection.19
While CADe publications have gone into great detail about the types and sizes of lesions
included, the complexity of the dataset is hard to determine simply from these metrics.
CADe systems were designed specifically to reduce the number of cancers missed by
radiologists by marking suspicious regions of interest, prompting radiologists to inspect the
annotated region. While the gold standard methodology for evaluation of a CADe system
should involve radiologists reviewing clinical cases without and then with CADe, it is also
useful to assess the cancer detection capability of the CADe system alone, without a
radiologist reader. The study objectives detailed in this paper were: i) to estimate the
sensitivity of each CADe system to known cancers when applied to digital and screen-film
mammography; ii) to compare the standalone sensitivities of each CADe system to the
original DMIST study sensitivities for digital and screen-film interpretation; iii) to report the
average number of false positive marks per case for each CADe system; and, iv) to estimate
the effect of tumor and patient characteristics on sensitivity.
MATERIALS AND METHODS
Appropriate institutional review board approval was obtained prior to conducting this study.
Informed consent and HIPAA consent were obtained from all evaluable subjects prior to
image acquisition for DMIST. All data were handled in a HIPAA compliant manner. Digital
and screen-film mammograms of the available DMIST pathologically-proven cancer cases,
i.e., those detected within 455 days of acquisition of the paired digital and screen-film
mammograms were included in this study. The screen-film and digital mammograms were
obtained from the American College of Radiology Imaging Network (ACRIN) image
archive. A total of 329 case pairs, including both digital and screen-film images, were
available for inclusion in this study out of a total of 335 DMIST cancer cases.
CADe Systems Tested
The CADe systems for screen-film and digital mammography of two manufacturers were
tested in this study: iCAD Secondlook v1.4 (digital and screen-film), R2 ImageChecker
Cenova v1.0 (digital), and R2 ImageChecker v 8.0 (screen-film). The results from the
default CAD sensitivity settings for each system were reported as the main results. In
addition to the default CAD sensitivity setting for R2 screen-film, two additional CAD
sensitivity settings were applied to a single digitized film set, and results are included in the
appendix. While any film mammogram can be processed using any film CADe system, not
all digital mammograms are suitable for processing with all digital CADe systems. At the
time of this study, the iCAD Secondlook v1.4 used in the study was compatible with images
from the Fuji CR, Hologic Selenia, and GE Senographe 2000D systems. The R2
ImageChecker Cenova CADe system tested was capable of analyzing images from the
Fischer SenoScan, Fuji CR, Hologic Selenia, and GE Senographe 2000D digital
mammography systems. The maximum available number of cases for each of our two digital
CADe systems was limited by these compatibility constraints. In total, 245 cases were
available for the iCAD digital system and all 329 cases were available for the R2 digital
system.
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De-identified screen-film mammograms were digitized using manufacturer specified
digitizer. CADe reports were printed to paper. Twenty-seven of the 329 available screen-
film mammograms (8.2%) were rejected by the iCAD screen-film digitizer and therefore
could not be digitized, resulting in 302 screen-film cases analyzed by iCAD. Twenty-six
cases of 329 (7.9%) available screen-film mammograms were rejected by the R2 film
digitizer and therefore could not be digitized, resulting in 303 screen-film cases analyzed by
R2.
Digital Image Preparation
Digital mammograms were processed with CADe and displayed on manufacturer specific
mammography workstations. The application of CADe algorithms was not successful for all
digital images. In total, there were 179 evaluable digital cases for iCAD and 227 digital
cases for R2. The CADe-generated electronic reports were displayed on a Hologic
Secureview 6.0 workstation for R2 (Figure 1) and a Sectra IDS5.MX review workstation for
iCAD (Figure 2).
Common Cases by Both Vendors
There are 161 common cases that were fully evaluated by both vendors, on both film screen
and digital mammograms. We focused our data analysis on those common cases, and
presented the patient and lesion characteristics of those cases on Table 1.
CADe Scoring Procedure
A radiologist with 26 years of mammography experience annotated acetate overlays with the
screen-film mammograms for each case (Figure 3), denoting the locations of known cancers
as seen on DMIST images and/or validated by DMIST pathology reports. The annotating
radiologist specified whether cancer was visible for each modality.
Three different radiologists reviewed the generated CADe marks and compared these to the
known cancer locations depicted on the overlays. All three readers completed breast imaging
fellowships and had an average of 4 years (range 2-8 years) experience in mammography.
An average of 48.3% (range 25%-70%) of their time was spent interpreting screening
mammograms in their respective clinical practices. One radiologist scored the iCAD digital
cases, a second radiologist scored the R2 digital cases, and a third radiologist scored all
digitized screen-film CADe for both R2 and iCAD. The radiologists recorded the number of
CADe marks generated, the location of each CADe mark, and determine whether the
location of each CADe mark corresponded to a known cancer as recorded on pathology
reports and the case overlay. Marks that did not correspond to a known cancer location were
recorded as false positives by the radiologists.
Statistical Methods
All statistics were performed at the case level to allow for comparison to DMIST results.
The study objectives were: i) to estimate the sensitivity of each CADe system to known
cancers when applied to digital and screen-film mammography; ii) to compare the
standalone sensitivities of each CADe system to the original DMIST study sensitivities for
digital and screen-film interpretation; iii) to report the average number of false positive
marks per case for each CADe system; and, iv) to estimate the effect of tumor and patient
characteristics on sensitivity. Sensitivity and the associated 95% exact confidence interval
for each CADe system were calculated and McNemar’s test was used to test the difference
between digital and screen-film within each CAD system. McNemar’s test and 95% exact
confidence intervals were used for the second objective. Mean, standard deviation, median,
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and number of false positive marks per case were calculated for the third objective and
paired t-test were used to test the difference between digital and screen-film within each
CAD system. To address the fourth objective, sensitivities for subsets defined by age, breast
density, menopausal status, cancer histology, tumor size, and lesion type were calculated by
simple counts as well as univariate logistic regression-based estimates. 95% confidence
intervals and p-values for comparing covariate effects on sensitivity were drawn from the
same logistic regression model.
RESULTS
We present the results for the default CADe sensitivity settings for screen-film and digital
for iCAD and R2 for the 161 common cancer cases.
Standalone Performance
There were 161 common cases across both screen-film and digital modalities for each CAD
vendor, allowing for modality comparison within each vendor. The overall sensitivity of
iCAD digital was 119/161 (0.74) [95% CI: (0.66, 0.81)] and 111/161 (0.69) [95% CI: (0.61,
0.76)] for screen-film. This difference in sensitivity between iCAD digital and screen-film
0.05 [95% CI: (−0.03, 0.13) was not statistically significant (p=0.26). The average number
of false CADe marks per case for iCAD digital (2.57±1.92) was significantly lower than that
for iCAD screen-film (3.06±1.72) (p=0.0008). The overall sensitivity of R2 digital was
119/161 (0.74) [95% CI: (0.66, 0.81)] and 97/161 (0.60) [95% CI: (0.52, 0.68)] for R2
screen-film. The difference in sensitivity between R2 digital and R2 screen-film 0.14 [95%
CI: (0.05, 0.23) was statistically significant (p=0.003). The average number of false CADe
marks per case for R2 digital (2.07±1.57) was significantly higher than for R2 screen-film
(1.52±1.45) (p <0.0001) (Table 2).
CADe Detection of Cancers Not Detected in the DMIST Study
In standalone mode, each CADe system for both screen-film and digital mammography was
able to detect significantly more cancer cases than were detected by the original clinical
radiologist readers in DMIST for the same cases. Of the 161 common cases, the original
DMIST study has sensitivity of 0.43 (69/161, 95% CI 0.35 to 0.51) for digital and 0.41
(66/161, 95% CI 0.33 to 0.49) for screen-film. For digital mammogram, both CADe
systems’ sensitivity for digital (0.74) was significantly higher than the DMIST’s sensitivity
(p< 0.0001). For screen-film, sensitivities for iCAD(0.69) and R2(0.60) were both
significantly higher than the DMIST’s sensitivity (p< 0.0001 for both) (Table 3).
In addition, CADe system has shown ability to detect the cases that were not detected by any
method in the DMIST study. Of the 46/161 cases that were detected by neither screen-film
nor digital readers in the primary DMIST study, 25 (54.3%) were marked by the iCAD
system when applied to digital, and 18(39.1%) when applied to screen-film. The comparable
numbers for R2 system is 27(58.7%) for digital and 12 (26.1%) for screen-film.
Lesion and Subject Characteristics Impact on Sensitivity
CADe’s sensitivity on lesion’s histology type (DCIS or invasive), size and type (mass,
calcification, asymmetric density and arch distortion), and the subject’s age, breast density,
and menopausal status was performed (Table 4) and compared using univariate logistic
regression models (Table 5). CADe sensitivity did not appear to depend on subject’s
characteristics, although the sensitivity of R2 screen-film was lower on pre-menopausal
women (49%) than on post-menopausal women (64%), but the difference was not
significant (p=0.09). Lesion histology type and size didn’t influence the sensitivity
significantly, but lesion type seemed to have some effect. In general, CADe had the highest
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sensitivity for calcification (83% for both iCAD and R2 digital, 73% for both iCAD and R2
screen-film), but R2 screen-film has a low sensitivity of 55% for mass, significantly lower
than the 73% for calcification on the same system (p = 0.038). In addition, asymmetric
density has low sensitivity of 50% on both iCAD and R2 digital, which are significantly
lower than the 83% for calcification ( p=0.017).
DISCUSSION
In this study, we evaluated the standalone sensitivity of commercial CADe systems to breast
cancers that were found at screening or follow-up in the DMIST study for both digital and
screen-film mammography. We found that the CADe systems tested were able to detect
significantly more cancers than were found on initial screening by the original radiologists
in DMIST for both digital and screen-film mammography; for each manufacturer,
standalone sensitivity was higher for digital than for screen-film; and the standalone
sensitivities of CADe systems was not influenced by lesion characteristics (histology, lesion
size, lesion type) or subject characteristics (age, breast density, menopausal status).
The overall average standalone CADe sensitivities reported here, ranging from 0.60 to 0.74,
are low compared to other retrospective standalone CADe studies. Bolivar et al reported a
digital R2 CADe sensitivity of 93% for a study that included cancers seen on both MLO and
CC views.20 The et al reported iCAD CADe sensitivity of 94% for cancers seen in at least
one screening view.21 Yang et al reported a sensitivity of 96.1% for cases that included only
a single cancer per subject detected by radiologists on digital mammograms.22 Our study
differed in that we included mammographically occult lesions. Besides mammographic
visibility of lesions, the characteristics of lesions and subjects have been shown to impact
radiologist sensitivity. In our study, there was no statistical difference in CADe sensitivity
based on breast density, lesion type, cancer histology, subject age, tumor size, and
menopausal status. The et al. reported no statistical difference in CADe sensitivity for their
study based on histopathology or tumor size.21 Bolivar et al reported no difference in digital
CADe sensitivity based on breast density, lesion type, or histopathology, but they did find a
significant difference based on tumor size for masses.20
One unique benefit of using the DMIST dataset for CADe evaluation was the ability to
assess the performance of CADe algorithms for both digital and screen-film mammography.
In our study, we used a single CADe system for both digital and screen-film with iCAD,
finding no difference in standalone CADe sensitivities between iCAD digital and screen-
film (p=0.26). For R2 digital and screen-film cases, two different versions of R2 CADe
algorithms were used. There was a significantly higher standalone CADe sensitivity for R2
digital than for R2 screen-film (p=0.003).
There were a few of limitations to this study. First, the methodology for scoring CADe mark
localization of known cancer locations could have introduced bias. Three different
radiologists conducted the scoring for screen-film (both iCAD and R2), iCAD digital, and
R2 digital. While we attempted to minimize this potential bias by providing the readers with
annotated overlays that directly matched the films generated by a fourth radiologist, the
radiologists that scored the digital CAD did have to use their judgment as to whether the
CADe mark shown on the computer screen overlapped the annotation on the overlay.
Second, because our study included only cancer cases, we could not assess specificity.
While higher sensitivity was realized under certain conditions, there is an unknown impact
on specificity. We are in the process of completing analysis of a retrospective radiologist
reader study that will allow us to assess the impact of CADe on radiologist sensitivity and
specificity with digital mammography. Third, the results provide the performance of CADe
at a given point in time. The algorithms tested were current at the time this study was
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performed in 2008-2009 timeframe. Certainly newer versions of these algorithms would be
available today resulting in perhaps different results. For reference we do provide results
from R2 CADe at different sensitivity settings in the appendix. Standalone CADe sensitivity
assessment is a critical first step in determining if a CADe algorithm is ready for clinical
assessment. Our results show that CADe marked between 26.1%-58.7% more cancers than
were detected by human readers alone, suggesting that the use of CADe with both screen-




The following tables represent the full R2 screen-film dataset including all three sensitivity
settings tested. R2-1 is the default sensitivity setting, with R2-2 having higher sensitivity
than the default setting, and R2-3 having the highest sensitivity setting allowed by the
system.
Table A-1









Age<50 64 (21.1) 65 (21.7) 61 (21.0)
50<=Age<=64 150 (49.5) 147 (49.0) 145 (49.8)
Age>=65 89 (29.4) 88 (29.3) 85 (29.1)
BREAST DENSITY
Dense Breasts 150 (49.5) 148 (49.3) 146 (50.2)
Fatty Breasts 153 (50.5) 152 (50.7) 145 (49.8)
MENOPAUSAL STATUS
Pre or Peri-Menopausal 90 (30.1) 91 (30.7) 87 (30.3)
Post-Menopausal 209 (69.9) 205 (69.3) 200 (69.7)
HISTOLOGY
DCIS 88 (29.1) 86 (28.8) 83 (28.6)
Invasive 214 (70.9) 213 (71.2) 207 (71.4)
TUMOR SIZE (mm)
Size<=5 43 (19.7) 42 (19.4) 39 (18.6)
5<Size<=10 56 (25.7) 56 (25.9) 55 (26.2)
Size>10 119 (54.6) 118 (54.6) 116 (55.2)
LESION TYPE
Mass 129 (48.9) 127 (48.7) 123 (48.2)
Asym Density 21 (8.0) 21 (8.0) 21 (8.2)
Calcification 99 (37.5) 98 (37.5) 96 (37.6)
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Arch Distortion 15 (5.7) 15 (5.7) 15 (5.9)
Table A-2





n/N 176/303 190/300 184/291
Estimate 0.58 0.63 0.63
95% CI (0.52,0.64) (0.58,0.69) (0.57,0.69)
False Positives
N 303 300 291
Mean 1.5 2.0 2.0
SD 1.42 1.65 1.64
Range (0, 7) (0,8) (0,8)
Median 1 2 2
n = number of correctly detected cancers
N = total number of cancer cases analyzable for each CADe system
95% CI = 95% exact confidence interval
SD =standard deviation
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Representative image of CAD marks and digital mammographic image R2. Δ symbol
indicates calcifications, while masses are circumscribed by a freeform shape.
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Screen shot of CC views of digital mammogram with iCAD report overlay. Square
represents calcifications and circle represents mass finding.
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Example of screen-film mammogram with annotated acetate overlay denoting location of
cancer.
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Table 1







Dense Breasts 75 (46.6)
Fatty Breasts 86 (53.4)
MENOPAUSAL STATUS













Asym Density 12 (7.5)
Calcification 60 (37.3)
Arch Distortion 8 (5.0)
Missing 16 (9.9)
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Table 2
















False Positive DG 2.57 ± 1.92 2.07 ± 1.57




95% CI: ( 0.33, 0.78)
p<0.0001
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Table 3
Comparison of Sensitivities of CADe system and DMIST Study for the Common Cases
iCAD R2
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